Cost of Some GLP-1 Agonists Exceed Weight-Loss Surgery
|
|
In general, medication treatment of a condition is considered to be less expensive than a surgical intervention. While that might be the case in the short term, it is not always that way in the long term. Find out how long before the cost of common glucagon-like peptide-1 (GLP-1) agonists for weight loss exceeds the expense of bariatric surgery for treatment of obesity.
|